Follow The Filings

ASND Ascendis Pharma A/S

Ascendis Pharma A/S earnings company data as of 7:04 PM ET 11/19

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS 1.13 — —
Rev $364.7M — —
FY2026 Q2 13 Aug EPS 0.78 — —
Rev — — —

Insider trades

Open-market buys and sales by ASND's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ASND insider trades
  • $777K bought by 2 insiders
  • $10.8M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Anni Lotte Kirstine Sonderbjerg Pedersen EVP & Chief Admin Officer
    Sale
    $5.3M 20,000 shares at $263.89 51% of stake
    Traded Nov 17 Filed Nov 18
  2. Mads Bodenhoff SVP & Pao
    Sale
    $811K 3,000 shares at $270.19 100% of stake
    Traded Sep 8 Filed Sep 9
  3. Lars Holtug Director
    Sale
    $62K 236 shares at $264.13 5.6% of stake
    Traded Sep 2 Filed Sep 3
  4. Jean Jacques Bienaime Director
    Buy
    $493K 2,000 shares at $246.33 +222% to stake
    Traded Aug 14 Filed Aug 18
  5. Scott Thomas Smith CFO
    Buy
    $22K 100 shares at $219.00 +2.3% to stake
    Traded Jun 2 Filed Jun 2
  6. Jean Jacques Bienaime Director
    Buy
    $112K 500 shares at $223.12 +125% to stake
    Traded May 29 Filed Jun 1
  7. Scott Thomas Smith CFO
    Buy
    $56K 250 shares at $223.32 +6.2% to stake
    Traded May 29 Filed Jun 1
  8. Jean Jacques Bienaime Director
    Buy
    $95K 400 shares at $237.80 New stake
    Traded May 26 Filed May 27
  9. Flemming Steen Jensen See Remarks
    Sale
    $4.6M 19,460 shares at $238.49 100% of stake
    Traded May 11 Filed May 12

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf